Stock Events

Stock Events

Merck 

€128.02
9512
-€0.76-0.59% 06:37 Today

Statistics

Day High
128.4
Day Low
128.02
52W High
136.74
52W Low
71.2
Volume
-
Avg. Volume
-
Mkt Cap
315.85B
P/E Ratio
129.42
Dividend Yield
2.36%
Dividend
3.02

Upcoming

Dividends

2.36%Dividend Yield
Oct 2026
€0.76
Jul 2026
€0.74
Apr 2026
€0.73
Jan 2026
€0.73
Oct 2025
€0.69
10Y Growth
6%
5Y Growth
6.18%
3Y Growth
3.06%
1Y Growth
1.6%

Earnings

Feb 2Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
-1.26
-0.1
1.07
2.23
Expected EPS
1.576956988
Actual EPS
N/A

Financials

28.17%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
56.46BRevenue
15.9BNet Income

Analyst Ratings

$123.04Average Price Target
The highest estimate is ⁦136.58⁩.
From 20 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6MK.STU. It's not an investment recommendation.
Microsoft
2196
MSFT
Realty Income
2133
O
Apple
1871
AAPL
Abbvie
1856
ABBV

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly with Merck in various therapeutic areas, including vaccines and oncology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and cancer treatments.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with Merck in the vaccines market and respiratory diseases.
Novartis
NVS
Mkt Cap303.67B
Novartis competes in multiple areas including oncology, neuroscience, and cardiovascular health.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Merck in areas such as immunology and oncology, particularly with its Humira product.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the oncology space, directly challenging Merck's Keytruda with its Opdivo.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly competes in the diabetes and cancer treatment markets, areas of focus for Merck.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes with Merck in areas such as oncology and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its Genentech subsidiary, competes in oncology, including direct competition in the PD-L1 inhibitor space.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Merck in the diabetes, cardiovascular, and vaccines markets.

About

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Show More
CEO
Robert Davis
Employees
75000
Country
United States
ISIN
US58933Y1055
WKN
000A0YD8Q

Listings

NEO
CA
MRK.NEO
BOATS
BOATS
MRK.BOATS
F
DE
6MK0.F
SN
CL
MRK.SN

0 Comments

Share your thoughts

FAQs

What is Merck stock price today?▼
The current price of 6MK.STU is €128.02 EUR — it has decreased by -0.59% in the past 24 hours. Watch Merck stock price performance more closely on the chart.
What is Merck stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Merck stocks are traded under the ticker 6MK.STU.
Is Merck stock price growing?▼
6MK.STU stock has risen by +0.2% compared to the previous week, the month change is a -0.09% fall, over the last year Merck has showed a +75.61% increase.
What is Merck market cap?▼
Today Merck has the market capitalization of 315.85B
When is the next Merck earnings date?▼
Merck is going to release the next earnings report on February 2, 2027.
What were Merck earnings last quarter?▼
6MK.STU earnings for the last quarter are 2.23 EUR per share, whereas the estimation was 1.86 EUR resulting in a +19.4% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Merck revenue for the last year?▼
Merck revenue for the last year amounts to 56.46B EUR.
What is Merck net income for the last year?▼
6MK.STU net income for the last year is 15.9B EUR.
Does Merck pay dividends?▼
Yes, 6MK.STU dividends are paid quarterly. The last dividend per share was 0.76 . As of today, Dividend Yield (FWD)% is 2.36%.
How many employees does Merck have?▼
As of November 4, 2026, the company has 75,000 employees.
In which sector is Merck located?▼
Merck operates in the Health & Wellness sector.
When did Merck complete a stock split?▼
Merck has not had any recent stock splits.
Where is Merck headquartered?▼
Merck is headquartered in RAHWAY, United States.